RF vs SGMT
RF (RF) versus Sagimet Biosciences Inc. Series A Common Stock (SGMT) — a side-by-side from cached financials, not a winner call.
RF (RF) common stock.
Sagimet Biosciences Inc. Series A Common Stock (SGMT) is a biotechnology company listed on NASDAQ.
RF does not have a complete income-statement cache yet.
Latest reported SGMT revenue for 2023-09-30 was $2.0M. Net income was -$6.4M. Revenue was up 0.0% from 2023-07-31 to 2023-09-30. SGMT currently screens at market cap $403.2M.
RF currently screens at market cap $0. SGMT currently screens at market cap $403.2M.
Not investment advice. Open the RF and SGMT stock pages for the full models.
Not investment advice.